CASSETTE —clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation: study protocol for a randomised controlled trial
This study will assess the effect of adjunctive clindamycin on patient-centred outcomes in severe, toxin-mediatedS. aureus infections. The pilot study will provide feasibility for a much larger RCT.Trial registrationAustralian New Zealand Clinical Trials Registry,ACTRN12617001416381p. Registered on 6 October 2017.
Source: Trials - Category: Research Source Type: clinical trials
More News: Anaphylactic Shock | Children | Clindamycin | Clinical Trials | Cubicin | Diarrhoea | Microbiology | New Zealand Health | Pneumonia | Pregnancy | Research | Septic Shock | Skin | Staphylococcus Aureus | Study